Providing a diverse range of perspectives from bullish to bearish, 12 analysts have published ratings on Colgate-Palmolive CL in the last three months.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 5 | 3 | 4 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 3 | 0 | 3 | 0 | 0 |
| 3M Ago | 2 | 1 | 1 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $96.67, a high estimate of $109.00, and a low estimate of $84.00. Surpassing the previous average price target of $90.91, the current average has increased by 6.34%.
Diving into Analyst Ratings: An In-Depth Exploration
The standing of Colgate-Palmolive among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Kevin Grundy | Exane BNP Paribas | Announces | Outperform | $109.00 | - |
| Dara Mohsenian | Morgan Stanley | Raises | Overweight | $103.00 | $101.00 |
| Chris Graja | Argus Research | Raises | Buy | $107.00 | $97.00 |
| Lauren Lieberman | Barclays | Raises | Equal-Weight | $85.00 | $84.00 |
| Chris Carey | Wells Fargo | Raises | Equal-Weight | $92.00 | $90.00 |
| Mark Astrachan | Stifel | Raises | Buy | $95.00 | $94.00 |
| Bryan Spillane | B of A Securities | Raises | Buy | $100.00 | $90.00 |
| Nik Modi | RBC Capital | Raises | Sector Perform | $95.00 | $88.00 |
| Filippo Falorni | Citigroup | Raises | Buy | $100.00 | $95.00 |
| Lauren Lieberman | Barclays | Raises | Equal-Weight | $84.00 | $82.00 |
| Mark Astrachan | Stifel | Raises | Buy | $94.00 | $89.00 |
| Robert Ottenstein | Evercore ISI Group | Raises | Outperform | $96.00 | $90.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Colgate-Palmolive. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Colgate-Palmolive compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Colgate-Palmolive's stock. This comparison reveals trends in analysts' expectations over time.
To gain a panoramic view of Colgate-Palmolive's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Colgate-Palmolive analyst ratings.
All You Need to Know About Colgate-Palmolive
Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's, which primarily sells its products through veterinarians and specialty pet retailers.
Unraveling the Financial Story of Colgate-Palmolive
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Positive Revenue Trend: Examining Colgate-Palmolive's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 6.18% as of 31 March, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Staples sector.
Net Margin: Colgate-Palmolive's net margin is impressive, surpassing industry averages. With a net margin of 13.48%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Colgate-Palmolive's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 162.81% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Colgate-Palmolive's ROA excels beyond industry benchmarks, reaching 4.14%. This signifies efficient management of assets and strong financial health.
Debt Management: Colgate-Palmolive's debt-to-equity ratio is notably higher than the industry average. With a ratio of 37.78, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Analyst Ratings: What Are They?
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
